Fusion Pharmaceuticals · 2 months ago
Director, Project Leadership
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radioconjugates as precision medicines. The Director of CMC Project Leadership will lead the pharmaceutical development strategy for the lead asset, FPI-2265, and represent CMC on the Global Program team, ensuring effective development, approval, and commercialization of new medicines.
BiopharmaBiotechnologyMedicalOncologyPharmaceutical
Responsibilities
Has overall accountabilìty for defining and delivering the pharmaceutical development strategy that delivers effective development, approval, commercialization and LCM of new medicines
The key CMC accountabilities include
The overall development and technical strategy
The regulatory strategy and documentation for marketing authorizations (incl IND/IMPD)
For in-market products, the role holder is accountable for the development and delivery of the Manufacturability Strategy & Plan
Clinical supply chain strategy and plan for Phase 3 (transferred generally at start of Phase 3)
Accountable to the Global Program Team (GPT) for maintaining and delivering all aspects of the pharmaceutical development plan including control of the scope, timing, resources, cost, quality and risk
An active member of the GPT, contributing to the development of overall project strategies. Is expected to have credibility and influence within the team in which the role holder is a member
Accountable for the technical development strategy for APl, DP & Analytical aligned with project strategy and priority
The role involves a diverse range of problems/opportunities requiring complex judgements and solutions based on highly developed levels of conceptual thought and strategic vision and analysis
May represent CMC on the evaluation of business development opportunities
Has the responsibility to ensure that project strategies are reviewed
Qualification
Required
10+ years experience in product development and manufacturing
Demonstrated strong leadership with enterprise mindset, learning agility, networking and negotiation skills and collaborative approach supportive of delivery of business objectives
Demonstrated strong interpersonal and communication skills with ability to set clear direction and objectives for the team and to influence at a senior level in the organization including Governance groups
Capable of managing the responsibilities for a diverse range of activities and projects acting as the key sponsor for projects and programs supporting their project portfolio
Excellent negotiation and influencing skills in order to influence and contribute to the cross-functional project/product strategies and deliverables
Possess strength and independence of viewpoint and be willing to challenge others in senior roles in other parts of Global Operations and the rest of the business when appropriate
Ability to develop & implement end-to-end Pharmaceutical strategy across all CMC areas (APl, DP, etc.) aligned with the overall GPT strategy and clinical/commercial supply
Significant experience of leading multi-disciplinary teams with an ability to ensure correct structure and team composition for efficient delivery and transition across the value stream
Strong coaching and motivational leadership skills that support the development of and delivery through the Pharmaceutical Team
Preferred
Advanced degree in Biochemistry, Pharmaceutical Chemistry, Pharmaceutics, Pharmaceutical Science, Chemical Engineering or related scientific discipline
PMP certification
Benefits
Eligibility for various incentives—an opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles.
Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage in accordance with the terms of the applicable plans.
Company
Fusion Pharmaceuticals
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.
Funding
Current Stage
Public CompanyTotal Funding
$230.91MKey Investors
CPP InvestmentsJohnson & Johnson Development Corporation
2024-03-19Acquired
2023-02-13Post Ipo Equity· $60M
2020-06-25IPO
Recent News
caixinglobal.com
2025-11-25
Company data provided by crunchbase